Find Academic Supervisors

Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.

• Epigenetics
• Retroelements
• Transposable elements
• +5 more

Sean Cao serves as Associate Professor (with tenure) at the Robert H. Smith School of Business, University of Maryland, where he is Director and Co-founder of the AI Initiative for Capital Market Research. He also holds an affiliation as professor at Harvard Business School's D 3 Institute. His academic journey began with a Ph.D. from the University of Illinois at Urbana-Champaign. Dr. Cao's research focuses on the intersection of artificial intelligence and capital markets, with particular expertise in how machine learning transforms financial analysis, corporate disclosure practices, and investment decision-making. His work examines the evolving relationship between human analysts and AI systems, blockchain applications in financial reporting, and the strategic adaptation of corporate communications for machine readership. He has pioneered research on the "AI divide" among investor groups and developed frameworks for human-AI collaborative stock analysis. His publication portfolio spans top journals including Journal of Financial Economics, Review of Financial Studies, Journal of Accounting Research, and Management Science. The research demonstrates consistent thematic progression toward increasingly sophisticated AI applications in finance, with recent work exploring distributed ledger technologies for auditing, machine learning for extracting private information from disclosures, and the economics of greenwashing in ESG funds. His studies frequently combine textual analysis with traditional financial metrics to uncover novel market insights. Fama-DFA Prize from Journal of Financial Economics for best paper in capital markets and asset pricing Michael J. Brennan Award from Review of Financial Studies Deloitte Initiative for AI and Learning award for developing trustworthy AI for social equity PanAgora Asset Management's Dr. Richard A. Crowell Memorial Prize Multiple best paper awards from Midwest Finance Association, Global AI Finance Conference, and Asian Finance Association Dr. Cao has delivered over 200 invited research talks at major institutions including the Central Bank of Japan, Central Bank of Thailand, and U.S. Securities and Exchange Commission. He serves as Guest Associate Editor for Management Science and has co-chaired Review of Financial Studies conferences on FinTech and Machine Learning. His educational initiatives include a widely adopted free AI textbook for finance and accounting that has been implemented at universities worldwide including Indiana University, UT Dallas, and University of Minnesota. As Director of the AI Initiative for Capital Market Research, Dr. Cao leads a multidisciplinary team exploring practical AI applications in finance. The initiative has secured significant funding including a $150,000 grant from GRF CPAs & Advisors. His research group maintains strong industry connections through partnerships with regulatory bodies, financial institutions, and technology companies, facilitating the translation of academic research into practical financial applications.

• Artificial Intelligence in Finance
• Machine Learning Applications
• Capital Market Research
• +5 more

Francesca Stradolini is a Lecturer at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the Electrical Engineering Doctoral School (EDEE). She holds a PhD in Electrical Engineering from EPFL (2018), with prior education in Bio Engineering and Neuroscience from the University of Genoa (2012, 2015). Her current work focuses on R&D engineering for medical devices, emphasizing system lifecycle management, human factors engineering, and compliance with CE/FDA regulations. As an invited guest, she contributes to usability engineering education and interdisciplinary research at EPFL. PhD: IoT Bio-Electronic Multi-Panel Device for On-line Monitoring of Anaesthesia Delivery (EPFL, 2018) MSc: Bio Engineering (University of Genoa, 2015) BSc: Bio Engineering (University of Genoa, 2012) Her research spans bioelectronics, IoT-enabled medical monitoring, and electrochemical sensor development for clinical applications. Key areas include anesthesia delivery systems, wearable diagnostics, implantable devices, and human factors engineering. Her work integrates fluidic systems, noble metal nanostructures, and open-source hardware (e.g., Raspberry Pi) to address challenges in traceability, fouling mitigation, and pharmacokinetic modeling. Scientific recognition includes the Ville de Lausanne Award (2019) , EPFL Outstanding PhD Thesis Distinction (2018) , and a Best Paper Award at MOBIHEALTH (2016) . She has published extensively in journals like IEEE TBIOCAS, Sensors and Actuators B, and IEEE Sensors Journal, with collaborative studies on propofol monitoring, carbon nanoallotrope drug detection, and implantable sensor validation. Her technical expertise includes managing medical device development lifecycles, designing IoT architectures for intensive care, and optimizing electrochemical sensors for stability in undiluted biological fluids. She has contributed to conferences such as IEEE BioCAS, ISCAS, and MOBIHEALTH, focusing on translational studies in personalized medicine and 3D-printed medical systems.

• Bioelectronics
• IoT for Medical Monitoring
• Anesthesia Delivery Systems
• +3 more

Roger Giner-Sorolla is Professor of Social Psychology at the University of Kent's School of Psychology, where he has been a faculty member since 2001 after completing his PhD at New York University in 1996. He served as Editor-in-Chief of the Journal of Experimental Social Psychology from 2016-2022 and currently leads a Leverhulme Foundation grant examining moral heroism across professions. His academic journey includes a postdoctoral fellowship at the University of Virginia and has established him as a leading figure in social and moral psychology. Professor Giner-Sorolla's research focuses on the social role of emotions, particularly moral emotions including self-condemning emotions (guilt and shame) and other-condemning emotions (anger, contempt, and disgust). His work extends to intergroup apologies, dehumanization, emotionally driven prejudice, and collective moral roles, with a notable side interest in the ironic enjoyment of music and aesthetic experiences. He is a strong advocate for transparency in scientific reporting, having written extensively on improved reporting guidelines, pre-registration, and open science practices. Analysis of his recent publications reveals a consistent focus on moral psychology with expanding interdisciplinary reach. His work bridges traditional social psychology with emerging areas including cross-cultural emotion research, replication science, and historical memory. The trend shows increasing attention to methodological rigor while maintaining core interests in emotion and morality, with growing emphasis on practical applications in conflict resolution and intergroup relations. Fellow of the Association for Psychological Science Member of Rising Stars selection committee (2023-2024) Promising Scholars Award (University of Kent, 2006) Vacation Research Scholarship (Wellcome Trust, 2005) Multiple ESRC grants totaling over £400,000 European Science Foundation Workshop Award (2004) Professor Giner-Sorolla has supervised an impressive number of PhD students, with 17 doctoral candidates listed in the documentation including both current and past students. His grant portfolio demonstrates significant research impact with funding from major organizations including ESRC, Wellcome Trust, and Leverhulme Foundation. His supervision style appears to encourage students to pursue research that aligns with his core interests in moral emotions while allowing exploration of novel applications and contexts. While the documentation doesn't specify laboratory or research team structures, his extensive collaborative work suggests leadership of research groups focused on moral psychology and emotion research. His numerous international collaborations and invited workshops indicate an active research program with global reach, likely involving multiple research teams working on interconnected projects related to his core interests in moral psychology and scientific methodology.

• Moral Psychology
• Social Psychology
• Emotion Research
• +7 more

John Oakey is a Professor and Graduate Coordinator in the Department of Chemical and Biomedical Engineering at the University of Wyoming, with additional affiliations to the INBRE Program, Molecular and Cellular Life Sciences Program, and Materials Science and Engineering Program. Education Postdoctoral Fellow, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School (2007–2010) Ph.D. Chemical Engineering, Colorado School of Mines (2003) M.S. Chemical Engineering, Colorado School of Mines (1999) B.S. Chemical Engineering, Penn State University (1997) Research Interests Oakey’s laboratory integrates fluid dynamics, colloidal science and materials science to understand how biological systems behave under flow, on surfaces and within complex 3-D geometries. A unifying theme is the use of microfabrication and microfluidics to create new diagnostic, prognostic and therapeutic platforms. Current thrusts include: Heterogeneous biomaterials: self-assembled particulate tissue scaffolds whose mechanical and transport properties can be temporally programmed. Inertial microfluidics: exploiting lift forces for membrane-free particle sorting, enrichment and diagnostics. Multi-temporal analysis by flow cytometry: development of closed-loop, high-throughput microfluidic cytometers for longitudinal single-cell studies. Publication Trends From 2025 back to 2010, Oakey’s articles reveal a consistent trajectory that marries fundamental physics (microtubule mechanics, inertial focusing) with translational applications (cell encapsulation, tissue scaffolds, drug delivery). Recent work (2023-2025) increasingly targets injectable granular hydrogels, single-cell therapeutic delivery and sustainable carbon-sequestering living materials, demonstrating an evolution from microscale transport phenomena to macroscopic biomedical and environmental impact. Scientific Awards No named awards are listed in the supplied text. Advising & Coordination Roles As Graduate Coordinator for the Department of Chemical and Biomedical Engineering, Professor Oakey oversees graduate program development and student mentoring. While no individual students are named, his role implies active supervision of M.S. and Ph.D. advisees in chemical and biomedical engineering. Laboratory & Teams The Oakey Research Group operates from the Energy and Environmental Research Building (EERB 435A) at the University of Wyoming. The lab enjoys R1-level research infrastructure and collaborates broadly with the Wyoming INBRE network, the Molecular and Cellular Life Sciences Program, and the Materials Science and Engineering Program.

• Microfluidics
• Microscale transport phenomena
• Tissue engineering and regenerative medicine
• +4 more

Snježana Babić serves as Associate Professor and Head of the Graduate Study Program Informatics - Teaching Major at the Faculty of Informatics in Pula , University of Pula. With a PhD obtained in 2016 and university affiliation since 2017, she teaches across undergraduate and graduate programs focusing on ICT fundamentals, web design, digital competencies, and informatics education methodology. Her educational background includes graduation in 1993 followed by doctoral studies culminating in 2016. Though specific institutions aren't detailed in the text, her career trajectory shows progression from foundational ICT teaching to specialized informatics education leadership. Babić's research centers on educational technology adoption with particular emphasis on programming pedagogy for young learners through the MEMA method. Her work investigates digital competencies across multiple educational contexts, from primary schools to higher education. Recent publications demonstrate rapid adaptation to emerging technologies, with 2025 studies examining ChatGPT integration in Croatian educational settings and cross-cultural applications of programming methods. Analysis of her 15 most recent publications reveals consistent focus on technology acceptance models applied to Croatian educators and students. The research trajectory shows evolution from foundational e-learning systems (2016-2020) to cutting-edge AI and robotics applications (2022-2025), maintaining strong methodological focus on teacher motivation , implementation barriers , and culturally-specific adoption factors . Her teaching portfolio demonstrates deep integration with research interests: Undergraduate: ICT Fundamentals, Web Design and Application Graduate: Digital Competencies in Education, Informatics Education Methodology, Practicum for IT Educators Cross-disciplinary: ICT in Nursing, Healthcare Informatics Babić actively contributes to institutional leadership as program head while maintaining robust research productivity. Her work bridges theoretical technology adoption frameworks with practical implementation challenges in Croatian educational contexts, particularly examining how emerging technologies like humanoid robots and AI assistants can be effectively integrated into teaching practices.

• Educational Technology
• Informatics Education
• Programming Pedagogy
• +3 more

Deborah Frances Smith is a Professor affiliated with the Centre for Immunology and Infection. She has held former roles including Head Of Department, Biology Pro-Vice-Chancellor for Research, and Special Adviser to the Vice Chancellor in the Vice Chancellor's Office. She is also associated with CNAP (Cancer and Neuroscience Academic Programme) and the Jack Birch Unit. Her research focuses on leishmaniasis, parasite biology, and drug/vaccine development. Key projects include leading the 'C2D2 research 1a & 2b' (2012–2012) to establish sandfly colonies for leishmaniasis studies and co-investigating an integrated crystallization facility (2013–2018). She secured the Wolfson Research merit Award (2009–2010) from the Royal Society. Her work spans academic leadership, collaborative research, and translational medicine targeting neglected tropical diseases.

• Leishmaniasis
• Immunology
• Parasitology
• +3 more

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +7 more

Min Yen Kan is an Associate Professor and Vice Dean of Undergraduate Studies at the National University of Singapore's School of Computing, Department of Computer Science. With a PhD from Columbia University (2002), he leads the Web Information Retrieval / Natural Language Processing Group (WING.NUS) and serves as ACL Ethics Committee co-chair. His research spans Natural Language Processing , Large Language Models , Digital Libraries , and Information Retrieval , with specific focus on scientific discourse analysis, fact verification, and multimodal systems. Current projects include Scholarly Document Information Extraction (TRL 6), Task-Oriented Dialogue Systems (TRL 4), and Recommendation Systems (TRL 5). Recent publications reveal strong trends in LLM limitations (bias, hallucination, evaluation), conversational recommendation systems , and misinformation detection . His work consistently bridges theoretical NLP with real-world applications in digital libraries and scientific communication. Award highlights include: CIKM 2019 Best Paper Award ACL Distinguished Service Awards Vannevar Bush Best Paper Award (JCDL 2012) ACM Distinguished Speaker designation Kan mentors PhD students with placements at Google and USTC, and serves as associate editor for Information Retrieval and survey editor for Journal of AI Research . His lab WING.NUS develops practical tools like SciWING for scientific document processing and FANG for fake news detection. Media engagements include commentary on AI regulations in Southeast Asia and workforce implications in the AI era.

• Natural Language Processing
• Large Language Models
• Digital Libraries
• +7 more

James B. Kaper is a Professor and Chair of the Department of Microbiology & Immunology at the University of Maryland School of Medicine. He serves as Vice Dean for Academic Affairs and previously held leadership roles as Senior Associate Dean (2014–2019) and Chair (2007–present). His research focuses on the molecular pathogenesis of diarrheagenic Escherichia coli and Vibrio cholerae , including vaccine development and bacterial-host interactions. Education: BS (1973) and PhD (1979) in Microbiology from University of Maryland; Postdoc in Molecular Pathogenesis at University of Washington (1979–1981) Dr. Kaper’s work has led to the creation of live attenuated cholera vaccines, including CVD 103-HgR, the first licensed recombinant bacterial vaccine. His lab investigates bacterial genetics, intestinal colonization, and immune system activation, particularly TLR5 response to V. cholerae flagellin. He has authored 303 peer-reviewed articles and 68 book chapters. His research has been funded continuously by NIAID since 1982. Key publications include foundational work on V. cholerae vaccines (1984), genomic structure (1998), and quorum sensing in EHEC/EPEC (1999). His lab’s recent studies focus on phosphotyrosine proteomics (2013) and pathogenicity island regulation (2007). Scientific awards: Fellow, American Academy of Microbiology (1994); NIH Merit Award (2004); ASM DC White Award (2019) Editorial roles: Editor-in-Chief, EcoSal (2006–present); Associate Editor, International Journal of Medical Microbiology (2000–present) As an academic leader, Dr. Kaper has mentored over 60 graduate students and postdoctoral fellows. He holds multiple patents for cholera vaccines and E. coli diagnostics, including U.S. Patents 4,935,364; 5,399,494; and 6,204,004. His lab at UMSOM combines basic science with translational applications for enteric disease prevention.

• Microbiology
• Immunology
• Bacterial Vaccines
• +5 more

Dr Martin Elliott is a Senior Research Fellow at the Children's Social Care Research and Development Centre (CASCADE), Cardiff University, and holds roles as Research Development Adviser for Health and Care Research Wales and academic lead for the all-Wales ExChange programme. His work focuses on child welfare inequalities, poverty, secure accommodation, and services for disabled children. With 17 years in statutory children’s services, he transitioned to academia via a PhD analyzing looked-after children in Wales. He has secured £3.4M+ in research funding, including a major CASCADE partnership grant. Educated with a DipSW (1997), BA(Hons) Community Studies (1998), MSc Social Science Research Methods (2013), and PhD (2018), his expertise spans mixed-methods research. Awards include the ESWRA doctoral thesis award (2020) and BASW’s British Journal of Social Work prize (2021). His research explores socio-economic dimensions in social work practice, policy impacts, and system equity. Key grants include studies on child welfare interventions, kinship care, and secure accommodation outcomes. He leads projects analyzing Wales’ Flying Start program, workforce regulation impacts, and crisis mental health services. CASCADE collaborates internationally on child welfare systems, reflecting his strategic focus on translating research into policy. His work bridges academic inquiry with frontline practice, addressing systemic challenges in child protection and welfare delivery.

• Child Welfare
• Secure Accommodation
• Poverty and Social Inequalities
• +3 more

Christopher Thomas Sege, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) College of Medicine. His research focuses on the neurophysiological mechanisms underlying anxiety disorders, particularly examining escape, avoidance, and approach behaviors in the anxiety disorder spectrum. Dr. Sege's primary research interests include: Anxiety Disorders and Emotional Processing Defensive Behaviors and Coping Mechanisms Neurophysiological Correlates of Emotional Anticipation Startle Response and Autonomic Nervous System Functioning Transcranial Magnetic Stimulation (rTMS) Applications His work bridges clinical psychology with neuroscience to understand how individuals with anxiety disorders process and respond to emotional stimuli. Dr. Sege leads the research study "Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum" which investigates whether repetitive transcranial magnetic stimulation (rTMS) can alter how people with anxiety cope with emotional situations. This study involves measuring brain activation while participants view emotional pictures and undergo rTMS procedures. His publication record demonstrates expertise across multiple domains: Neurophysiological mechanisms of defensive behaviors Emotional anticipation and perception Startle modulation in anxiety disorders Borderline personality disorder research Development of experimental paradigms for emotional processing studies His research employs multiple methodologies including psychophysiology, event-related potentials, and neurostimulation techniques. Dr. Sege collaborates with researchers including Lisa McTeague, Bernadette Cortese, Carla Danielson, Thomas Uhde, and Aicko Schumann. His work appears in journals such as Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Biological Psychology, and Psychophysiology.

• Anxiety Disorders
• Neurophysiology
• Emotional Processing
• +4 more

Dr. Samira Lakhal-Littleton is an Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow at the University of Oxford, affiliated with the Department of Physiology, Anatomy and Genetics and Brasenose College. Her research focuses on iron homeostasis, systems biology, and oxygen sensing mechanisms in cardiovascular and systemic physiology. Education: BSc in Human Genetics (University College London), DPhil in Molecular Medicine (University of Oxford) Her work bridges cell physiology and translational medicine, with key discoveries on hypoxia-inducible factors (HIFs), iron regulatory genes TMPRSS6 and GDF15 , and the role of hepcidin in altitude adaptation and chronic diseases. She utilizes tissue-specific animal models to study iron regulation in heart, kidney, placenta, and vasculature. Recent publications highlight her contributions to understanding: FLASH radiotherapy effects linked to iron-dependent lipid peroxidation Clinical implications of myocardial iron dynamics in heart failure Hepcidin's role in vascular protection and placental iron transfer Biomarker development for predictive iron deficiency diagnostics Scientific Leadership: British Heart Foundation Intermediate Fellowship (2012) MRC Senior Fellowship (2020) BioIron Society Board Member (2019) She collaborates with clinical teams on translational projects and serves as a Tutorial Fellow in Medicine at Brasenose College, mentoring students in physiological sciences.

• Iron Homeostasis
• Cell Physiology
• Systems Biology
• +4 more

Karen Piper Hanley is Professor of Molecular Medicine and Head of Division in the Division of Diabetes, Endocrinology & Gastroenterology at the University of Manchester. She serves as the fibrosis lead in the Wellcome Trust Centre for Cell-Matrix Research and previously served as Director of Core Research Technologies (2019-2022). She is also an editorial board member for Scientific Reports. Her research focuses on fibrosis (scarring) mechanisms across multiple organs, particularly liver, kidney, and lung fibrosis. Her lab investigates the cellular and molecular basis of fibrotic disease, with emphasis on how pathological scar components are produced and how they signal to surrounding cells. Key areas include the role of SOX9 transcription factor, integrin beta-1 signaling, Group 1 PAKs, and YAP1 in fibrosis progression. Her recent publications reveal trends toward increased clinical translation of fibrosis research, with studies on health inequalities in liver cancer care, post-COVID diabetes incidence, and innovative approaches to liver disease detection. Her work increasingly integrates spatial transcriptomics and advanced omics technologies to understand cellular transitions in liver disease. Career-track postdoctoral fellowship from the University of Southampton (2006) As senior postgraduate tutor, she has mentored numerous PhD students who have presented at key conferences and authored high-quality manuscripts. All her PhD students have submitted and been awarded their degrees within 4 years. She has successfully guided previous Academic Clinical Fellows to win MRC clinical training fellowships. Her teaching extends to undergraduate Personal & Professional Development and supervision of MRes and BSc students, many of whom have achieved first-class degrees and prestigious awards. Her lab maintains active collaborations with Professor Neil Hanley's group on human development, stem cells, and regenerative medicine, bridging developmental biology with fibrosis research to understand why regeneration is impaired in chronic diseases.

• Fibrosis Research
• Liver Fibrosis
• Kidney Fibrosis
• +9 more

Ting Lu is an Associate Professor at the University of Illinois at Urbana-Champaign in the School of Biomedical and Translational Sciences, focusing on microbial synthetic biology and systems biology. Their research bridges biology, engineering, and physics to reprogram cellular functionalities through gene regulatory networks. Ph.D. in Biophysics, University of California at San Diego (2007) B.S. in Physics, Zhejiang University (2002) Ting Lu's work explores microbial ecosystems, synthetic gene circuits, and their applications in biotechnology and medicine. By combining experimental approaches with mathematical modeling, they investigate bacterial communication networks, metabolic pathways, and spatial dynamics in microbial communities. Selected research trends include microbial consortia engineering for bioremediation and bioproduction, complexity reduction in microbiomes, and predictive modeling of synthetic gene networks. Their publications span high-impact journals such as Nature Communications , Nature Chemical Biology , and eLife . Fellow, American Institute for Medical and Biological Engineering (2022) Future Insight Prize (2021) Donald Biggar Willett Faculty Scholar (UIUC) (2020) NIH Maximizing Investigators' Research Award (2019) NSF CAREER Award (2015) AHA National Scientist Development Grant (2012) Ting Lu's lab has received grants from NIH, NSF, ONR, and industry partners. They offer undergraduate research opportunities in synthetic and systems biology, and teach advanced courses such as BIOE 430 - Intro Synthetic Biology and BIOE 432 - Systems Biology .

• Synthetic Biology
• Systems Biology
• Quantitative Biology
• +5 more